130 related articles for article (PubMed ID: 33468783)
1. [MSI-H Small Bowel Cancer with Peritoneal Dissemination Successfully Treated with Pembrolizumab-A Case Report].
Moriuchi T; Shimizu Y; Shimizu W; Sada H; Kubota H; Tahara S; Komo T; Hadano N; Tazawa H; Suzuki T; Onoe T; Ishiyama K; Sudo T; Tashiro H
Gan To Kagaku Ryoho; 2020 Dec; 47(13):2009-2011. PubMed ID: 33468783
[TBL] [Abstract][Full Text] [Related]
2. [A Case of MSI-High Sigmoid Colon Cancer in Which Long-Term Survival Was Achieved by Pembrolizumab for Recurrent Lesions Resistant to Conventional Chemotherapy].
Tsumuraya H; Kaneta A; Fujita S; Hayashishita S; Mochizuki S; Suzuki H; Takiguchi C; Matsuishi A; Maruyama Y; Kanouda R; Sakuma M; Sakamoto W; Monma T; Saze Z; Kono K
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1742-1744. PubMed ID: 38303192
[TBL] [Abstract][Full Text] [Related]
3. [A Case of Advanced Recurrent Colorectal Cancer with Complete Response to Pembrolizumab Chemotherapy].
Ishiguro T; Ishikawa H; Muta Y; Ito T; Chikatani K; Chika N; Amano K; Hatano S; Suzuki O; Mori Y; Kumagai Y; Ishibashi K; Mochiki E; Ishida H
Gan To Kagaku Ryoho; 2020 Dec; 47(13):2299-2301. PubMed ID: 33468940
[TBL] [Abstract][Full Text] [Related]
4. Pembrolizumab in advanced recurrent endometrial cancer: A cost-effectiveness analysis.
Barrington DA; Dilley SE; Smith HJ; Straughn JM
Gynecol Oncol; 2019 May; 153(2):381-384. PubMed ID: 30808517
[TBL] [Abstract][Full Text] [Related]
5. [A CASE OF URACHAL CARCINOMA WITH HIGH FREQUENCY MICROSATELLITE INSTABILITY (MSI-HIGH) TREATED BY PEMBROLIZUMAB].
Tokita T; Iuchi S; Noto N; Hashizume A; Higuchi K; Miyama K; Kawai M; Nakamura K
Nihon Hinyokika Gakkai Zasshi; 2022; 113(2):68-72. PubMed ID: 37081655
[TBL] [Abstract][Full Text] [Related]
6. Pembrolizumab response in stage IV luminal-type breast cancer with high microsatellite instability: a case report.
Inakami K; Fujita N; Iguchi C; Enomoto Y; Minohata J; Sata A; Miyagawa Y; Yanagisawa T; Saitoh T; Nomura T; Sawai Y; Takahara K; Kasugai T; Shiba E
J Med Case Rep; 2024 May; 18(1):214. PubMed ID: 38689362
[TBL] [Abstract][Full Text] [Related]
7. [Long-Term Elderly Survivor with Recurrent MSI-High Gastric Cancer Using Pembrolizumab as a Second-Line Chemotherapy].
Hamada S; Komatsu S; Nishiko M; Konishi T; Matsubara D; Soga K; Shimomura K; Ikeda J; Taniguchi F; Shioaki Y
Gan To Kagaku Ryoho; 2022 Jan; 49(1):83-84. PubMed ID: 35046369
[TBL] [Abstract][Full Text] [Related]
8. Microsatellite Instability-high Intrahepatic Cholangiocarcinoma with Portal Vein Tumor Thrombosis Successfully Treated with Pembrolizumab.
Naganuma A; Sakuda T; Murakami T; Aihara K; Watanuki Y; Suzuki Y; Shibasaki E; Masuda T; Uehara S; Yasuoka H; Hoshino T; Kudo T; Ishihara H; Ogawa T; Kitamoto Y; Ogawa A
Intern Med; 2020 Sep; 59(18):2261-2267. PubMed ID: 32536644
[TBL] [Abstract][Full Text] [Related]
9. Clinical activity of pembrolizumab in metastatic prostate cancer with microsatellite instability high (MSI-H) detected by circulating tumor DNA.
Barata P; Agarwal N; Nussenzveig R; Gerendash B; Jaeger E; Hatton W; Ledet E; Lewis B; Layton J; Babiker H; Bryce A; Garje R; Stein C; Kiedrowski L; Saylor P; Sartor O
J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32788235
[TBL] [Abstract][Full Text] [Related]
10. [A Case of Advanced Gastric Cancer with Peritoneal Dissemination after Gastrectomy Successfully Treated with Paclitaxel plus Ramucirumab].
Miyamoto K; Tadano Y; Itoh R
Gan To Kagaku Ryoho; 2021 Jan; 48(1):113-114. PubMed ID: 33468738
[TBL] [Abstract][Full Text] [Related]
11. Methylation and microsatellite status and recurrence following adjuvant FOLFOX in colorectal cancer.
Han SW; Lee HJ; Bae JM; Cho NY; Lee KH; Kim TY; Oh DY; Im SA; Bang YJ; Jeong SY; Park KJ; Park JG; Kang GH; Kim TY
Int J Cancer; 2013 May; 132(9):2209-16. PubMed ID: 23034738
[TBL] [Abstract][Full Text] [Related]
12. Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part I-Colorectal Cancer: Microsatellite Instability, Testing, and Clinical Implications.
Marginean EC; Melosky B
Arch Pathol Lab Med; 2018 Jan; 142(1):17-25. PubMed ID: 29144791
[TBL] [Abstract][Full Text] [Related]
13. Pathological complete response to pembrolizumab in patients with metastatic ascending colon cancer with microsatellite instability.
Tominaga T; Nonaka T; Fukuda A; Moriyama M; Oyama S; Ishii M; Sawai T; Okano S; Nagayasu T
Clin J Gastroenterol; 2022 Feb; 15(1):134-139. PubMed ID: 34708305
[TBL] [Abstract][Full Text] [Related]
14. FOLFIRI plus bevacizumab as a first-line treatment for Japanese patients with metastatic colorectal cancer: a JACCRO CC-03 multicenter phase II study.
Kochi M; Akiyama Y; Aoki T; Hagiwara K; Takahashi T; Hironaka K; Teranishi F; Osuka F; Takeuchi M; Fujii M; Nakajima T
Cancer Chemother Pharmacol; 2013 Nov; 72(5):1097-102. PubMed ID: 24057041
[TBL] [Abstract][Full Text] [Related]
15. [A case wherein bevacizumab/XELOX combination therapy was remarkably effective for the treatment of extensive dissemination in advanced colon cancer, and the primary lesion could be resected].
Kubo H; Nakasuga C; Tada K; Miyahara M; Hasegawa H
Gan To Kagaku Ryoho; 2013 Nov; 40(11):1545-8. PubMed ID: 24231712
[TBL] [Abstract][Full Text] [Related]
16. [Pembrolizumab as first-line therapy in microsatellite instability metastatic colorectal cancers].
Pureur D; Rodrigues M; Turpin A
Bull Cancer; 2021 Mar; 108(3):229-231. PubMed ID: 33632546
[No Abstract] [Full Text] [Related]
17. [A case report of successful treatment for rectosigmoid cancer with peritoneal dissemination after neoadjuvant chemoradiotherapy with XELOX and bevacizumab].
Ishida M; Miyazawa T; Ebe K; Koide N; Fujita N; Honma K; Ikarashi T
Gan To Kagaku Ryoho; 2013 Jan; 40(1):103-5. PubMed ID: 23306929
[TBL] [Abstract][Full Text] [Related]
18. Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study.
Cohen EEW; Soulières D; Le Tourneau C; Dinis J; Licitra L; Ahn MJ; Soria A; Machiels JP; Mach N; Mehra R; Burtness B; Zhang P; Cheng J; Swaby RF; Harrington KJ;
Lancet; 2019 Jan; 393(10167):156-167. PubMed ID: 30509740
[TBL] [Abstract][Full Text] [Related]
19. Case report: reinitiating pembrolizumab treatment after small bowel perforation.
Beck TN; Kudinov AE; Dulaimi E; Boumber Y
BMC Cancer; 2019 Apr; 19(1):379. PubMed ID: 31018834
[TBL] [Abstract][Full Text] [Related]
20. Pembrolizumab in combination with ipilimumab as second-line or later therapy for advanced non-small-cell lung cancer: KEYNOTE-021 cohorts D and H.
Gubens MA; Sequist LV; Stevenson JP; Powell SF; Villaruz LC; Gadgeel SM; Langer CJ; Patnaik A; Borghaei H; Jalal SI; Fiore J; Saraf S; Raftopoulos H; Gandhi L
Lung Cancer; 2019 Apr; 130():59-66. PubMed ID: 30885353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
